Microarray data profiles gene expression on a whole genome scale, and provides a good way to study associations between gene expression and occurrence or progression of cancer disease. Many researchers realized that microarray data is useful to predict cancer cases. However, the high dimension of gene expressions, which is significantly larger than the sample size, makes this task very difficult. It is very important to identify the significant genes causing cancer. Many feature selection algorithms have been proposed focusing on improving cancer predictive accuracy at the expense of ignoring the correlations between the features. In this work, a novel framework (named by SGS) is presented for significant genes selection and efficient cancer case classification. The proposed framework first performs a clustering algorithm to find the gene groups where genes in each group have higher correlation coefficient, and then selects (1) the significant (2) genes in each group using the Bayesian Lasso method and important gene groups using the group Lasso method, and finally builds a prediction model based on the shrinkage gene space with efficient classification algorithm (such as support vector machine (SVM), 1NN, and regression). Experimental results on public available microarray data show that the proposed framework often outperforms the existing feature selection and prediction methods such as SAM, information gain (IG), and Lasso-type prediction models.
Introduction
Cancer is a class of diseases for which a group of cells undergoes uncontrolled growth. It causes destruction of adjacent tissues and sometimes spreads to other locations in the body via lymph or blood. The American Cancer Society stated that about 7.6 million people died from cancer in the world during 2007, and nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. Various research efforts based on surgery, chemotherapy, and radiotherapy, are being made to fight against cancer. Recently, more and more researchers began to study gene expression profiles obtained by microarray technology. Microarray data profiles gene expression on a whole genome scale and provides a good way to study associations between gene expression and occurrence or progression of cancer [Ramaswamy and Golub (2002) ]. It has been used extensively in applications, ranging from basic molecular biology research, through testing drug treatment effectiveness, and up to clinical diagnosis of cancer patients based on their gene expression profiles. Thus, microarray data analysis has a profound impact on cancer research [Golub (2001) ].
In microarray data analysis, there exists a big challenging problem. Indeed, the dimension of gene expressions is much larger than the sample size and this makes it a hot and hard research topic [Donoho and Jin (2008) ; Jin (2009)] . In order to solve this problem, feature selection [Peng et al. (2005) ], which is a technique of selecting a minimal subset of original features for best predictive classification accuracy, has attracted strong interest in the past several decades, for instance in text mining, image processing. Among them, researchers made use of feature redundancy techniques [Appice et al. (2004) ], which minimize redundancy and maximize relevance among selected features for classification. In the field of bioinformatics, a large amount of efforts have also been made to identify relevant or important genes that have influential effects on diseases including varieties of cancers.
For example, statistical approaches for gene selection and predictive model building have been widely studied and designed. Existing approaches include the singular value decomposition [Golub and van-Loan (1996) ], principal component analysis [Ma et al. (2006) ; Costa et al. (2009) ], partial least squares [Nguyen and Rocker (2002) ], sparse logistic regression [Shevade and Keerthi (2003) ; Cawley and Talbot (2006) ], Lasso [Gui and Li (2005) ; Tibshirani (1996) ; Park and Casella (2008) ], support vector machine [Guyon et al. (2002) ; Ding and Wilkins (2006) ], information gain [Jirapech-Umpai and Aitken (2005) ], fuzzy theory [De and Ghosh (2009) ], SAM [Tusher et al. (2001) ] and its extension [Tibshirani et al. (2002) ]. These approaches aim at improving the cancer classification accuracy by identifying important genes, a small subset of genes or linear combinations of genes often referred to as super genes which can best explain the phenotype variations. Of course, gene selection has other important applications, say finding the percentage of overlapping genes from different microarray expressions for a same disease and determining the consistency between two DEG lists . Additionally, enrichment value is also a measure to evaluate the biological meaning of selected gene sets [Subramanian et al. (2005) ; Sivachenko et al. (2007) ].
In high dimensional cancer disease data, there are several sets of highly correlated genes. The above mentioned feature selection methods obtain many different subsets of genes that may result about the same or similar classification accuracy results [Ein-Dor et al. (2005) ; Kalousis et al. (2007) ]. Therefore, the methods are not necessarily reliable to identify candidate genes for subsequent costly biological validation. In order to handle this problem, Unger and Chor [2008] presented a linear separating method (named as LinSep) to find all gene pairs such that the projection of all samples according to each gene pair can be separated, which to the large extent identified all important genes for sample class classification and meanwhile considered the relationship between genes. However, LinSep is used to project the samples on all gene pairs and then select the best gene pairs, thus it is computationally expensive. Yu et al. [2008] and Loscalzo et al. [2009] proposed stable feature selection approaches via dense and consensus feature groups, DRAGS and CGS respectively. First, they identified feature groups where all features in each group are as much correlated to each other as possible, and then applied the selection method on the feature group level where each group is treated as a single entity. Yuan and Lin [2006] presented group Lasso (named as grpLasso) to identify the important gene groups where the covariates are partitioned into groups. DRAGS, CGS, and grpLasso are able to find the important correlated gene groups but they cannot identify the important individual genes in each gene group.
In this paper, a hybrid strategy is presented to effectively select important genes from microarray data and accurately classify the cancer samples. The proposed method combines the clustering step, the Bayesian Lasso step, the group Lasso step, and the classification step. These four steps have essential connections between them. Here, the clustering step provides the gene group label based on genes' correlation coefficients to the group Lasso step. The Bayesian Lasso method identifies a stable subset of important genes for each group to rerepresent the cancer data after the shrinkage procedure. The group step Lasso selects the important gene groups based on the obtained group labels and the shrinkage data representation, and finally the classification step builds a classification model to predict cancer data based on the data after the shrinkage. Experimental results have shown that the proposed strategy performs well in cancer data applications.
The rest of our paper is organized as follows. In Sec. 2, some related and typical gene selection methods in bioinformatics is given. Section 3, we describe the proposed hybrid framework. In Sec. 4, a series of experimental results is presented and discussed. A conclusion is given in Sec. 5.
Related Works
Gene selection is necessary, important, and difficult for cancer identification [Donoho and Jin (2008); Jin (2009); De and Ghosh (2009)] . Therefore, it is a hot research topic. There are many available statistical approaches for gene selection and predictive model building which consider high dimensional microarray data. In this section, several popular methods for gene selection in microarray data analysis are briefly reviewed, such as information gain (IG) [Jirapech-Umpai and Aitken (2005) ], SAM method [Tusher et al. (2001) ], and Lasso-type methods [Tibshirani (1996) ; Zou and Hastie (2005) ; Yuan and Lin (2006) ; Park and Casella (2008) ].
Clearly, IG is a feature-goodness criterion in the field of machine learning [Mitchell (1996) ]. Recently, it was used in text mining [Yang and Pedersen (1997) ; Dasgupta et al. (2007) ], and predictive gene identification [Jirapech-Umpai and Aitken (2005) ]. Further, IG measures the amount of information that presence or absence of a particular gene contains about the category of the sample:
where P (g), P (c), and P (g, c) measure the probability of a gene, a tissue category (cancer or normal), and both a gene and a tissue category appear in the whole cancer sample set, respectively. The IG measures the number of bits of information obtained for category prediction by knowing the presence or absence of a gene in a sample. Tusher et al. proposed a method to analyze the significance of genes for ionizing radiation response (SAM method [Tusher et al. (2001)] ). The relative difference of each gene is defined as
where µ k (i) is the average levels of expression for the ith gene in class k. Further, s(i) is the standard deviation of repeated expression measurements (or the samples), called as gene-specific scatter, and n k is the number of samples in class k.
The above methods, IG and SAM, select genes according to their corresponding score. The higher the score, the more important the genes. In order to identify important genes, these methods require a threshold to cut the whole gene sets and then keep the genes with larger score. In practice, cross validation is used to choose a suitable value of threshold.
Recently, the least absolute shrinkage and selection operator (Lasso), a shrinkage method, has been widely used in regression analysis for large models [Tibshirani (1996) ]. The Lasso procedure can be interpreted as a Bayesian posterior mode estimate when assigning an independent double-exponential prior to each coefficient [Tibshirani (1996) ; Yuan and Lin (2006) ; Park and Casella (2008) ]. Owing to the nature of the l 1 -penalty, the Lasso does both continuous shrinkage and automatic variable selection simultaneously. Standard Lasso approach carries out variable selection at the individual gene level and takes the form
Under the name of basis pursuit denoising model (BPDN) [Chen et al. (1999) ], it is now a rather developed research field in signal processing. For instance, it is usually applied for compression, source separation [Starck et al. (2005) (2007)]). Meanwhile, lots of efforts have also been concentrated to numerically solve the Lasso-type model efficiently (see [Malgouyres and Zeng (2009); Hale et al. (2008) 
]).
Although the Lasso penalty leads to sparse models, it does have two serious drawbacks. First, Lasso is instable when the data is high dimensional. In order to deal with this problem, several researchers proposed new Lasso-type estimators based on Tibshirani' analysis result [Tibshirani (1996) ]. Here, the Lasso can be interpreted as posterior mode estimates when the regression parameters have independent and identical Laplace (i.e., double-exponential) priors. Zou [2006] proposed an adaptive Lasso estimator by introducing adaptive data-driven weights and using Laplace-like priors. Park and Casella [2008] adopted Bayesian posterior mode estimate and marginal maximum likelihood to automatically find the best parameter. Zou and Hastie [2005] proposed an elastic net estimator (enLasso) to select the correlated variables as follows
The l 1 -norm part of Eq. (4) performs automatic variable selection, while the l 2 -norm part stabilizes the solution paths and, hence, improves the prediction. However, parameter λ 1 for l 2 -norm penalty makes elastic net become hard control, so does adaptive elastic net estimator 
Second, the Lasso does not contain any prior information about, e.g., possible groups of covariates that one may wish to select them jointly. Several researchers have recently proposed new penalties to enforce the estimation of models with specific sparsity patterns. Yuan and Lin [2006] presented the group Lasso to deal with the case where the covariates are partitioned into groups. The group lasso [Yuan and Lin (2006) ; Meier et al. (2008) ] (referred to as grpLasso) is designed for selecting groups of covariates by optimizing the following estimator
where I g is the index set belonging to the gth group of genes, g = 1, . . . , G. This penalty can be viewed as an intermediate between l 1 -norm and l 2 -norm penalties. It has the attractive property that it can select gene at the group level and is invariant under (groupwise) orthogonal transformations like ridge regression. Direct application of the group Lasso can identify important gene groups. However, it is not capable of selecting important genes within the selected groups.
Novel Framework for Gene Selection and Cancer Prediction
In this section, a novel framework for both selecting important genes and building cancer prediction model is presented. The proposed framework effectively combined several data mining techniques: clustering algorithms based on Pearson coefficient, sparse feature selection methods, covariates selection methods, and classification algorithms, as shown in Fig. 1 . The new framework adopted the combination of these four techniques, so that kept the merits of existing algorithms (such as, enLasso for sparse individual feature selection and the group Lasso for covariates identification) and filled up the drawbacks of them (say, enLasso cannot identify covariates, while the group Lasso cannot select important genes in each group [Jacob et al. (2009)] ). In the proposed framework, partitioning around medoids (PAM) [Kaufman and Rousseeuw (1990) ] clustering algorithm was adopted to identify the gene groups. PAM represent each cluster with one of its own object, i.e., the representative object is a centrotype. However, PAM is more robust than k-means because it minimizes a sum of dissimilarities instead of a sum of squared Euclidean distances, which is one reason why PAM algorithm was used here. The other reason is that PAM operates on the dissimilarity matrix of the given cancer gene expression data, in this case, the dissimilarity between two genes (x and y) is calculated with the Pearson correlation coefficients (as shown in Eq. (6), which is a popular and efficient similarity metric in gene expression profiles analysis [Attwood and Smith (1999) 
The dissimilarity between x and y is defined by
, where n is the number of samples in the cancer data. Meanwhile, Pearson coefficient will be helpful for later grpLasso step of our framework. However, like k-means, PAM required the number of clusters k as the input parameter. Here, a big range of k was tested and the best k was identified with weighted inter-intra index (W tertra) [Strehl (2002) ].
where
Similarity(x, y) and
p is the number of total genes, p i is the number of genes in the ith cluster, inter(i, j) is the similarity between the ith and the jth clusters, while, intra(i) is the similarity in the ith cluster. In order to find a desirable clustering result, with high overall cluster quality (i.e., maximizing intra-cluster similarity and minimizing inter-cluster similarity) and a small number of clusters k, the clustering result with the highest Wtertra value was adopted. In other words, PAM with Pearson correlation coefficient and Wtertra index can identify the gene groups where the genes in each group are covariates because they have higher correlation coefficient (i.e., similarity). Let us take a real cancer dataset, colon data including 2,000 genes and 62 samples [Alon et al. (1999) ], as an example to show the performance of PAM and Wtertra. Figure 2 gives the clustering validation results (k from 2 to 100) of PAM on colon data set. The best number of gene groups in colon data is 6 according to Fig. 2 . Table 1 gives the cluster sizes at the best clustering result on colon data set. The clustering step provides the gene group label to supervise the group Lasso step in our proposed framework.
The group Lasso [Yuan and Lin (2006) ] can be used to identify the important gene clusters for cancer prediction with the above obtained gene cluster labels, but the group Lasso has bad ability to select the important individual genes [Jacob et al. (2009)] . Therefore, Lasso [Tibshirani (1996) ], a technique encouraging sparsity in individual coefficients based on a small set of samples, was applied on each gene group to identify a small subset of informative genes, called marker genes, which discriminate between the tumor and the normal tissues, or between different kinds of tumor tissues. Recall the above colon example, six gene groups were obtained, which means that Lasso would be applied six times and once for each group. Considering the difficulty of parameter selecting in Lasso, here, the Bayesian Lasso (BLasso) [Park and Casella (2008) ] was adopted, which can approximate the ideal updated penalty parameter λ with marginal maximum likelihood during the iteration process. Figure 3 lists the gene (variable) coefficients distribution for each colon gene group, where the genes with nonzero coefficient are marker genes, i.e., important to discriminate the cancer and normal tissue samples.
Once the important genes are identified in each group, all tissue samples can be represented with these important genes and their group labels. For example, the genes are clustered into K groups by PAM and W tertra index, and the kth group has m k important genes identified by BLasso, then the tissue sample X i will be represented as a vector with
Finally, the cancer data set is rerepresented as a n-by-D matrix. In the new representation model, the genes in each group are more similar than the genes in different group. Among them, the similarity between genes are calculated by the Pearson correlation coefficient metric, therefore, genes in the same group are covariates in the whole dataset. Recall the theory of group Lasso (Eq. (5)), identifying the group of covariates, the group Lasso can be applied on the new cancer data representation under the supervision of group labels.
As we know, the accuracy of the classification model depends strongly on how the input data is represented. Typically, the input data is transformed into a feature vector containing a number of features that are descriptive of the data. Because of the curse of dimensionality, the number of features should not be too large, but should be large enough to accurately predict the output. In our proposed hybrid framework for cancer prediction, the number of final selected important genes (i.e., features) are not too large but large enough to build the classification model, because these genes are identified by an effective integrated method which combines clustering, Bayesian Lasso and group Lasso. For the classification models, support vector machine (SVM) [Scholkopf et al. (1999) ] k-nearest neighbors (KNN) [Shakhnarovich et al. (2005) ], and logistic regression [Hosmer and Lemeshow (2000) ] were adopted. Further, SVM is a popular and efficient linear classifier by finding a hyperplane so that the distance from it to the nearest data points on each side is maximized, especially, for two-class cancer prediction case. The KNN algorithm is the simplest machine learning algorithm, which classifies a data point by a majority vote of its neighbors, in our case, K was set to be 1, i.e., the data is simply assigned to the class of its nearest neighbor. In addition, logistic regression can be used here to predict the probability of occurrence of an event by fitting data to a logistic curve. Actually, our framework can adopt any classification algorithm in this step.
In the next section, the proposed method is applied on the real cancer datasets and the experimental results are reported. The proposed method combines clustering step, the Bayesian Lasso step, the group Lasso step and classification step. These four approaches have important connections. Indeed, the clustering approach provides the gene group label based on their correlation coefficients to the later group Lasso, the Bayesian Lasso method identifies a series of important genes for each group to rerepresent the cancer data in the shrinkage space, the group Lasso selects the important gene groups based on the obtained group labels and the shrinkage data representation, and finally the classification approach builds a classifying model to predict cancer data based on the important shrinkage space. The clustering algorithm measures the correlation between features effectively, thus it is helpful for the group Lasso to select the import covariates. The Bayesian Lasso effectively shrinks the sparsity of the gene space, therefore, it is useful for the group Lasso and classification model building. As these methods are related to each other, their integration is consistent and is thus expected to provide efficient results.
Experimental Results and Discussion
The proposed hybrid framework was tested with the real cancer data, colon cancer data [Alon et al. (1999) ], Leukemia data [Golub et al. (1999) ], breast cancer data [West et al. (2001) ], SRBCT data [Khan et al. (2001) ], prostate cancer via cDNA microarray data [Lapointe et al. (2004) ], and prostate cancer via oligomicroarray data [Singh et al. (2002) ]. The colon cancer data describes the expression of 2,000 genes in 40 cancer and 22 normal tissue samples, the aim being to construct a classifier capable of distinguishing between cancer and normal tissues. The aim of the leukemia benchmark is to form a decision rule capable of distinguishing between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The data describes the expression of 7,129 genes in 47 ALL samples and 25 AML samples. The breast cancer dataset is consisted of 49 tumor samples in 7,129 genes. This data provides two functions. One is to build a classifier to distinguish into estrogen receptor-positive (ER+) tumor samples and estrogen receptor-negative (ER−) ones, the other is to classify the tumor samples lymph node-positive (LN+) and lymph node-negative (LN−). Further, SRBCT contains the expression levels of 2,308 genes for 83 small round blue cells tumor patients belonging to one of the four categories: Ewing family of tumors (EWS) with 29 samples, rhabdomyosarcoma (RMS) with 25 samples, neuroblastoma (NB) with 18 samples, and non-Hodgkin lymphoma (BL) with 11 samples. The prostate cancer on cDNA microarray data consists of 62 tumors and 41 normal samples, while the oligomicroarray data contain 52 tumors and 50 normal samples. These two platforms share 6,797 genes, which were used in the experiments.
For SAM and IG scoring methods, the number of genes was selected same with the number of genes obtained by SGS method, and applied SVM and 1NN classification algorithms on the selected gene space. Further, BLasso and grpLasso were compared with the proposed framework in two ways. One is using BLasso or grpLasso as the gene selection method and then adopts SVM and 1NN to build the cancer prediction model. For the whole dataset, the best penalty parameter λ of BLasso was automatically determined during the iteration, and the corresponding numbers of selected genes are 27 for colon, 71 for leukemia, 48 for breast (LN), 48 for breast (ER), 41 for SRBCT, 41 for prostate cancer cDNA data, and 42 for prostate cancer oligodata, respectively. The other way is directly running BLasso and grpLasso to predict the samples with logistic regression method, and their results were compared with the prediction results obtained by the integrated method SGS and logistic regression model.
Our proposed hybrid method identified that the best cluster numbers are 6 for colon, 54 for leukemia, 49 for breast (LN), 54 for breast (ER), and 19 for SRBCT, respectively (for all data, set k from 2 to 100). The number of selected genes is 20 for colon, 49 for leukemia, 33 for breast (LN), 36 for breast (ER), 32 for SRBCT, 43 for prostate cancer cDNA data, and 21 for prostate cancer oligodata. Tables 2 and 3 show the classification accuracy of the above seven datasets. The first evaluation method (Table 2) is 10-fold validation on training data and the second one (Table 3) is classification accuracy on testing data. According to the experimental results, the proposed hybrid gene selection method (SGS) significantly outperforms the existing feature selection methods like BLasso, grpLasso, SAM, and IG.
Meanwhile, the gene weights (for leukemia data) and their distribution were listed, where gene weights were obtained by these three methods (SGS (Fig. 4(a) ), SAM (Fig. 4(b) ), and IG (Fig. 4(c) ).) and the weights distribution between the proposed SGS and the other two methods SAM (Fig. 4(d) ) and IG (Fig. 4(e) ). Figure 4 (a) makes us conveniently select the important genes with nonzero weights, however, SAM and IG scoring methods have to predefine a threshold to choose the significant genes. The comparison distributions between SGS and SAM scores, and between SGS and IG scores indicate that not all genes with higher SAM score or IG score have higher SGS score. Meanwhile, the selected genes by SGS (as shown in Table 5 ) were checked by the biologists and they found that most of such genes are empirically useful to determine ALL and AML, and thus SGS methods are more favorable than SAM and IG to identify significant genes for cancer prediction. The reason why SGS performs better than BLasso and grpLasso is that SGS efficiently integrated both of them and clustering algorithm, so that SGS keeps the merits of BLasso and grpLasso and simultaneously addressed their drawbacks. Furthermore, comparing with the prediction accuracy 82.3% of BLogReg on colon data [Cawley and Talbot (2006) ], 93.1% of BLogReg on leukemia data [Cawley and Talbot (2006) ], 81.9% of SLogReg on ER breast data [Shevade and Keerthi (2003) ], 92.1% of enLasso on leukemia data [Zou and Hastie (2005) ], our proposed hybrid framework also performs better than them.
Furthermore, the final selected genes were checked, especially for colon data, leukemia data, and SRBCT data, to confirm whether the identified genes are related to the cancer samples. Table 4 shows the selected significant genes from colon cancer data. Among them, Gene Hsa.3016 is an S-100P protein. Further, 100P is well known to be expressed in human cancers, including breast, colon, prostate, and lung, therefore, its expression level was correlated with resistance to chemotherapy. Similar to our work [Kishino and Waddell (2000) ] also identified that Hsa.1039 and Hsa.627 were associated with colon cancers. In addition, Hsa.140 and Hsa.1737 were also selected by [Fung and Ng (2007) ], although the gene selection procedure adopted there was different from the one used in the proposed method. Gene Hsa.462 a has been shown to be significantly correlated to colon tissues. Bolmont et al. [1990] proved that Human desmin gene (Hsa.8147) played an important role in colon disease. Hsa.36689, Hsa.37937, and Hsa.2291 were identified by Shevade and Keerthi [2003] and the first two and Hsa.6814 were also identified by Li et al. [2002] . Tristetraprolin (Hsa.1682) was examined to have ability to regulate COX-2, which increases in colon tumor microenvironment, i.e., Hsa.1682 is observed during colon tumorigenesis [Young et al. (2009)] . Hsa.8214 has been shown to be associated with tumor cell proliferation in general, while Hsa.696 was revealed to be related to small intestine, colon, testis, and leukocytes by RT-PCR analysis. Meanwhile, researchers revealed that Hsa.1454 acts as a negative regulator of the LEF-1/beta-catenin transcription complex, thereby protecting cells from development of cancer [Knippschild et al. (2005) ]. Estrogen sulfotransferase (Hsa.42949) can inhibit competitively the activation of promutagenic estrogen metabolites into carcinogens, so that it has protective effect for colon cancer. Table 5 shows a list of the important 49 genes for leukemia data identified by the proposed SGS method. Among them, 44 genes have been empirically proved to be discriminative genes between ALL and AML [Golub et al. (1999) ]. For the other five genes M27830, M11722, M12886, M14483, and X00437, although there is no exact biological experiments to show they can determine the difference between ALL and AML, our results can help the biologist to design future laboratory experiments to confirm the confidence of the relationship between gene and cancer samples. As we know, when biologists choose gene candidates, due to the difficulties intrinsic in the biological experiments, it is not feasible for them to validate a large number of genes. Therefore, our experimental results are meaningful. Table 6 gives the important 32 genes belonging to seven clusters from SRBCT data selected by our proposed method. We further investigated the gene clusters in detail, and found that genes in different clusters are related to different sample categories by referring to Khan et al. [2001] . For example, genes in cluster 1, cluster 4, cluster 15, and cluster 19 are strongly related to samples in EWS, BL, LGALS3 lectin, galactoside-binding, soluble, 3 (galectin 3) (Note: redefinition of symbol) M19045 LYZ lysozyme M83652 PFC properdin P factor, complement RMS, and NB categories, respectively. Genes in cluster 7 are related to samples both in EWS and RMS, genes in cluster 12 are related to samples both in EWS and NB, while genes in cluster 16 are relative to samples both in EWS and BL. In others words, our proposed method is also efficient to identify important genes for different sample categories. Finally, the consistence between two selected gene lists is checked. The experiments were conducted on prostate cancer cDNA and oligo microarray data because both datasets describe the same disease. The consistency metrics used in the experiments contain POG and POGR ]. Among them, POG measures the consistence by counting overlapped genes between the gene lists, and POGR evaluates the consistence by counting both overlapped genes and their significantly positively correlated genes. Table 7 shows the results. From Table 7 , we can see that the number of genes shared by two selected gene lists from cDNA and oligo microarray data respectively is very small, but the genes are significantly positively correlated with each other in the selected list. That is why the POGR is usually greater than POG which is more or less consistent with the previous report by ]. For POGR from cDNA to oligomicroarray data, SAM obtained the best consistency result in terms of POGR ab , grpLasso is the second one, and SGS is the third one. Recall the idea of SGS, the BLasso was used in each gene group to select the important genes and then grpLasso was adopted to select the important gene groups that only contain their important genes. In the same time, the genes were divided into different groups according to their Pearson correlation coefficients, therefore, the correlation between the selected genes via SGS is larger than BLasso while less than grpLasso to some extent. For POGR from oligo to cDNA microarray data, the proposed method SGS outperforms others. Thus, we can say SGS has comparative ability to find the consistency gene lists from different microarray data for a complex disease.
Conclusions and Future Work
A hybrid gene selection method was presented in our paper. The hybrid method effectively integrated three techniques, clustering, Baybesian Lasso, and group Lasso, so that it can identify both the important individual gens and their correlated genes. The clustering algorithm based on Pearson coefficient metric provides supervision information (e.g., group labels) for group Lasso, and Bayesian Lasso extracted important individual genes for each group, thus the final step, group Lasso, can efficiently find the significant gene groups where each group only contains the important correlated genes. Based on this hybrid gene selection method, the original cancer data is represented in the selected genes space, and then any classification algorithm (such as, SVM, 1NN, and Regression) can be applied to build the prediction model. Experimental results on four cancer datasets have shown that our proposed method (SGS), in most cases, performs better than the existing gene selection methods, say, SAM, IG, Lasso-type. Meanwhile, SGS is empirically proven to find the consistency gene lists from different expression profiles for a complex disease.
